<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151382">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01942889</url>
  </required_header>
  <id_info>
    <org_study_id>UF 8710</org_study_id>
    <nct_id>NCT01942889</nct_id>
  </id_info>
  <brief_title>Antioxidants and Pulmonary Rehabilitation in COPD Patients</brief_title>
  <acronym>AREB-1</acronym>
  <official_title>Antioxidants Supplementation Associated With Pulmonary Rehabilitation is it Effective on Muscle Dysfunction and Signaling Pathways Involved in the Myopathy of COPD?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Groupe Fontalvie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      On the basis of published data and investigators results indicating that systemic redox in
      balance may contribute to the peripheral muscle dysfunction in COPD patients, the
      investigators propose a study testing the effects of antioxidants and exercise training in
      COPD patients.  The results may have major implication in the improvement of pulmonary
      rehabilitation benefits
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COPD will constitute the third cause of mortality in 2012. This chronic respiratory disease
      is characterized by peripheral dysfunction of skeletal muscle which is associated with major
      clinical outcomes (prognostics, symptoms, and health related quality of life). Muscle and
      systemic oxidative stress has been incriminated in this peripheral muscle
      dysfunction.Exercise training constitute the main validated therapeutic intervention leading
      to significant muscle function and clinical improvement.Our preliminary results have shown
      that COPD patients experiment dietary and enzymatic antioxidants defects.Yet, generic
      antioxidant supplementation has not shown significant muscle function improvement.Therefore,
      we aim to test the effects of an antioxidant supplementation targeted on the antioxidant
      defects associated with exercise training on the peripheral muscle function, exercise
      tolerance and health quality of life in COPD patients.At the cellular level, this muscle
      dysfunction is related with a fiber atrophy and a metabolic switch (reduce proportion of
      oxidative fiber).This study will compare the effects of an antioxidant supplementation on
      the peripheral muscle function and skeletal muscle cellular properties in association with
      exercise training during a pulmonary rehabilitation course.Volunteers will be randomised in
      2 groups: - 1 group treated with the antioxidant supplementation ( 28 days)- 1 group treated
      with the placeboIntervention will be allocated by chance and a double blind manner.
      Antioxidant supplementation will associate vitamins and trace elements that won't exceed the
      maximal nutritional dose recommended.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>quadriceps endurance timeTime frame:  at the start and the end of the study</measure>
    <time_frame>up to day 37</time_frame>
    <safety_issue>No</safety_issue>
    <description>Description: sitting on a bench with a force sensor connected to a data acquisition and analysis system signal, subjects should reproduce three trials spaced 1 minute, by an extension movement of the knee joint against a stationary load, maximum way, keeping the arms crossed over the chest and leaning against the back in order to limit the involvement of other muscles. The most elevated of the three tests repeatable value close to 10% characterizes the maximum strength of subjects.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>muscle and /or serum oxidative stress level</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Description:  oxidative stress will be evaluated by measuring lipid peroxidation and oxidized proteins.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Antioxidant Supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin antioxidant and trace elements combination that won't exceed the maximal nutritional dose recommended in France (Vit E, vit C, Selenomethionine, Zinc gluconate).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Antioxidant Supplementation associated to Comprehensive respiratory Rehabilitation Program</intervention_name>
    <description>Vit E, Vit C, Selenomethionine, Zinc gluconate</description>
    <arm_group_label>Antioxidant Supplementation</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD patients,  40 years to 78 years, last exacerbation dating at least 4 weeks

        Exclusion Criteria:

          -  unstabilized primary pathologies (cardiovascular, renal, metabolic, psychiatric)

          -  nutritional supplementation in the 4 weeks preceding the study (antioxidant,
             vitamins…)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>78 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maurice Hayot, PU-PH</last_name>
    <email>m-hayot@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bronia Ayoub</last_name>
    <email>a-bronia@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinique du souffle la vallonie</name>
      <address>
        <city>Lodève</city>
        <zip>34700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bronia AYOUB</last_name>
      <phone>+33(4)67330824</phone>
      <email>b-ayoub@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe De Rigal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bronia AYOUB</last_name>
      <email>b-ayoub@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Maurice Hayot, PU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Farès GOUZI, AHU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques Mercier, PU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Préffaut, PU-PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <lastchanged_date>September 10, 2013</lastchanged_date>
  <firstreceived_date>August 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>exercise training</keyword>
  <keyword>pulmonary rehabilitation</keyword>
  <keyword>antioxidant</keyword>
  <keyword>muscle</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Antioxidants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
